Provenienza dei contatti di primo grado di Meg M. Silverman
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance Thomas, McNerney & Partners LLC (Thomas McNerney & Partner) is a venture capital subsidiary of the Coral Group Inc founded in 1998. The firm is headquartered in Minneapolis, Minnesota.
1
| Extinct | Investment Managers | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Meg M. Silverman tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| University of Michigan | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| EIDOS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Chief Operating Officer | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| The Bluefield Project to Cure Frontotemporal Dementia | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 14 |
| Svizzera | 2 |
Settori
| Health Technology | 8 |
| Finance | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 5 |
| Chief Operating Officer | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
| Private Equity Analyst | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Christine Siu | 15 |
- Borsa valori
- Insiders
- Meg M. Silverman
- Connessioni Società
